References

 

  1. Bode, L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22, 1147–1162 (2012).
  2. German, J. B., Freeman, S. L., Lebrilla, C. B. & Mills, D. a. Human Milk Oligosaccharides: Evolution, Structures and Bioselectivity as Substrates for Intestinal Bacteria. Nestle Nutr Work. Ser Pediatr Progr. 62, 205–222 (2008).
  3. Kunz, C., Rudloff, S., Baier, W., Klein, N. & Strobel, S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 20, 699–722 (2000).
  4. Chaturvedi, P. et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 11, 365–72 (2001).
  5. Thurl, S. et al. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br. J. Nutr. 104, 1261–71 (2010).
  6. Wu, S., Tao, N., German, J. B., Grimm, R. & Lebrilla, C. B. Development of an annotated library of neutral human milk oligosaccharides. J. Proteome Res. 9, 4138–51 (2010).
  7. Bode, L. The functional biology of human milk oligosaccharides. Early Hum. Dev. 91, 619–622 (2015).
  8. Morrow, A. L. et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J. Pediatr. 145, 297–303 (2004).
  9. Weichert, S. et al. Bioengineered 2’-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr. Res. 33, 831–8 (2013).
  10. Weichert, S. et al. Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides. J. Virol. 90(9), 4843-8. (2016).
  11. Triantis, V. Human milk oligosaccharides block infection of commonly circulating human rotaviruses in an in vitro model. FASEB posters (2015).
  12. Yu, Z. T. et al. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 23, 169–177 (2013).
  13. Harmsen, H. et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr2 30, 61–67 (2000).
  14. Castillo-Courtade, L. et al. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy Eur. J. Allergy Clin. Immunol. 70, 1091–1102 (2015).
  15. Sprenger, N. et al. FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk. Eur. J. Nutr. Epub, (2016).
  16. Holscher, H. D., Davis, S. R. & Tappenden, K. A. Human milk oligosaccharides influence maturation of human intestinal Caco-2Bbe and HT-29 cell lines. J. Nutr. 144, 586–91 (2014).
  17. Autran, C. A., Schoterman, M. H. C., Jantscher-Krenn, E., Kamerling, J. P. & Bode, L. Sialylated galacto-oligosaccharides and 2’-fucosyllactose reduce necrotising enterocolitis in neonatal rats. Br. J. Nutr. 116, 294–299 (2016).
  18. Vázquez, E. et al. Effects of a human milk oligosaccharide, 2’-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. J. Nutr. Biochem. 26, 455–65 (2015).
  19. Oliveros, E. et al. Oral Supplementation of 2’-fucosyllactose during lactation improves memory and learning in rats. J. Nutr. Biochem. 31, 20–27 (2016).
  20. Matsuki, T. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat. Commun. 7, 11939 (2016).
  21. Puccio, G. et al. Effects of Infant Formula with Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. JPGN 64, 624–631 (2017)
  22. Marriage, B. J., Buck, R. H., Goehring, K. C., Oliver, J. S. & Williams, J. A. Infants Fed a Lower Calorie Formula With 2’FL Show Growth and 2’FL Uptake Like Breast-Fed Infants. J. Pediatr. Gastroenterol. Nutr. 61, 649–58 (2015).
  23. Cilieborg, M.S. et al. Minimal short-term effect of dietary 2′-fucosyllactose on bacterial colonisation, intestinal function and necrotising enterocolitis in preterm pigs. Br J Nutr, 116(5): 834-41 (2016)
  24. Autran, C.A. et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut. (2017).
  25. Goehring, K.C. et al. Similar to Those Who Are breastfed, infants Fed a Formula containing 2′-Fucosyllactose Have Lower inflammatory cytokines in a Randomized controlled Trial. J Nutr, 146(12), 2559-2566 (2016).
  26. Elison, E. et al. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-n-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr, 116(8), 1356-1368 (2016).
  27. Laucirica, D.R. et al. Milk Oligosaccharides inhibit Human Rotavirus infectivity in MA104 cells. J Nutr, (2017).
  28. Lewis, Z.T. et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome, 3, 13, (2015).